Integrated preformulation, analytical characterization and post-compression assesment of <span style="font-size: 1rem;">diclofenac sodium</span>
Current Trends in Pharmacy and Pharmaceutical Chemistry · 15.06.2026 · 8 (2) · 76-80
DOI: 10.18231/j.ctppc.28764.1781522898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Trends in Pharmacy and Pharmaceutical Chemistry, online erschienen am 15.06.2026. Verfasst von Tejashree Maule und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Diclofenac sodium is a widely used non-steroidal anti-inflammatory drug (NSAID) that exhibits potent analgesic, anti-inflammatory, and antipyretic activities. It is extensively prescribed for the management of various painful and inflammatory disorders, such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, musculoskeletal injuries, and postoperative pain. The drug exerts its therapeutic effect by suppressing cyclooxygenase-mediated prostaglandin synthesis.Aim & Scope: The present study aimed to formulate and evaluate oral diclofenac sodium tablets to achieve acceptable pharmaceutical properties andoptimized drug release characteristics suitable for effective clinical use.Materials and Methods: The tablets were prepared using standard pharmaceutical techniques. The developed formulations were subjected to comprehensive evaluation, including pre-compression parameters (powder flow properties) and post-compression quality control tests (physicochemical attributes and in vitro dissolution profiles).
Results
The formulated tablets demonstrated satisfactory physicochemical characteristics, complying fully with established official quality control specifications. Evaluation studies confirmed efficient and uniform drug release from the developed formulations.
Conclusion
The findings of this investigation suggest that the formulated diclofenac sodium tablets possess desirable pharmaceutical attributes. This developed formulation represents a stable and effective solid oral dosage form for the management of acute and chronic inflammatory conditions.
Zitieren
APA
Maule, T., Kushare, S., Ahire, A., Mahanor, A., Choudhari, P., Ugale, D., More, S., & Wagh, S. (2026). Integrated preformulation, analytical characterization and post-compression assesment of diclofenac sodium. Current Trends in Pharmacy and Pharmaceutical Chemistry, 8(2), 76-80. https://doi.org/10.18231/j.ctppc.28764.1781522898
Vancouver
Maule T, Kushare S, Ahire A, Mahanor A, Choudhari P, Ugale D, et al. Integrated preformulation, analytical characterization and post-compression assesment of diclofenac sodium. Current Trends in Pharmacy and Pharmaceutical Chemistry. 2026;8(2):76-80. doi:10.18231/j.ctppc.28764.1781522898
BibTeX
@article{Maule2026,
author = {Maule, Tejashree and Kushare, Sakshi and Ahire, Arushi and Mahanor, Aishwarya and Choudhari, Pooja and Ugale, Dipti and More, Shruti and Wagh, Suyog},
title = {Integrated preformulation, analytical characterization and post-compression assesment of diclofenac sodium},
journal = {Current Trends in Pharmacy and Pharmaceutical Chemistry},
year = {2026},
volume = {8},
number = {2},
pages = {76--80},
doi = {10.18231/j.ctppc.28764.1781522898}
}
EUVIMED